An American Capital Strategy for 2008

Recs

29

Conservatism seems to be the name of the game at Income Investor recommendation American Capital Strategies (Nasdaq: ACAS).

On Wednesday, the company announced its results for the fourth quarter and full year of 2007, and gave its outlook for 2008. Taking the bear by the horns (can you even do that?), the company started with the assumption that the U.S. will slide into recession in 2008, leaving the company unable to raise any new capital. Far from pessimistic, CEO Malon Wilkus almost seemed excited to prove that the company will "continue to perform well in 'steady state' mode."

So what might this look like for investors? To start with, the company reiterated its 2008 dividend forecast of $4.19 per share. If it delivers, that would be a 13% boost from 2007, and a 12%-plus yield on the current stock price. The company has already gotten a head start bringing these dividends to fruition, too -- it announced the rollover of excess taxable gains from 2007, which will cover nearly two quarters of 2008 dividend payments.

This assumes, of course, that things don't go too far off the tracks for American Capital in the coming year. Though 2007 ended well on the whole, American Capital's portfolio took a hit in the fourth quarter. Overall, the company took a $417 million unrealized loss, primarily from the decline in value of its ownership stake in European Capital and mark-to-market declines for its commercial mortgage-backed and collateralized debt. So far, it appears that the losses the company has taken are primarily market-driven -- as opposed to fundamental-driven -- but that will certainly be tested if we do head into genuine recession territory.

American Capital finished the year with a net asset value (NAV) per share of $32.88, up 12% from the prior year. This puts the stock slightly above NAV, giving it a premium valuation similar to peers like Prospect Capital (Nasdaq: PSEC) and Allied Capital (NYSE: ALD), but above other business development companies like Apollo Investment (Nasdaq: AINV) and MCG Capital (Nasdaq: MCGC).

The valuation likely reflects the greater confidence that investors have in American Capital's portfolio and the management team's ability to navigate troubled waters. If American Capital's recession projection is right, the company will certainly have a chance to prove whether this confidence is warranted.

Further financial Foolishness:

Follow along with the Global Gains team as they travel to key business centers in China to uncover the very best investing opportunities! Sign up here to receive their FREE dispatches from the road.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 579138, ~/articles/ArticleHandler.aspx, 7/6/2009 5:55:18 PM

Keep Reading:

“An American Capital Strategy for 2008”

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Get involved! »

Most Recent

Jul 6 at 4:01 PM

Market Summary

DJIA 8,324.87 +44.13 +0.53%
S&P 500 898.72 +2.30 +0.26%
NASD 1,787.40 -9.12 -0.51%
Sponsored by:

Related Tickers

American Capital, Ltd.

CAPS Rating 3/5 Stars

$3.10

+0.02 (+0.65%)

Outperform1854

Underperform115

Rate This Stock